Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 32 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 9902713

    Neuroprotective compounds and use thereof

    The Board of Regents of the University of Texas System · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted

  2. US 9895413

    Protection against and treatment of ionizing radiation

    The Board of Regents of the University of Texas System · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  3. US 9895328

    Calcium formate as a supplement to prevent neural tube defects

    The Board of Regents of the University of Texas System · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  4. US 9895429

    Antibodies that bind amyloid oligomers

    The Board of Regents of the University of Texas System · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  5. US 9896561

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  6. US 9889092

    Low density lipoprotein nanocarriers for targeted delivery of omega-3 polyunsaturated fatty acids to cancer

    The Board of Regents of the University of Texas System · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  7. US 9889081

    Aldehyde dehydrogenase inhibitors as novel depigmenting agents

    The Board of Regents of the University of Texas System · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  8. US 9890216

    Antibodies with engineered IgG Fc domains

    The Board of Regents of the University of Texas System · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  9. US 9884863

    STAT3 inhibitor

    The Board of Regents of the University of Texas System · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

  10. US 9884820

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

  11. US 9879260

    Micro-RNA regulation of bone loss

    The Board of Regents of the University of Texas System · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  12. US 9872926

    Multicolored pH-activatable fluorescence nanoplatform

    The Board of Regents of the University of Texas System · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted

  13. US 9868777

    CMV neutralizing antigen binding proteins

    The Board of Regents of the University of Texas System · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  14. US 9856206

    Oligo-benzamide compounds and their use

    The Board of Regents of the University of Texas System · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  15. US 9856233

    Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins

    The Board of Regents of the University of Texas System · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  16. US 9849174

    Methods and compositions related to immunogenic fibrils

    The Board of Regents of the University of Texas System · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

  17. US 9850542

    Gene signature to predict homologous recombination (HR) deficient cancer

    The Board of Regents of the University of Texas System · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

  18. US 9846160

    Ganglioside GD2 as a marker and target on cancer stem cells

    The Board of Regents of the University of Texas System · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

  19. US 9840583

    Fluorescent polymers and applications thereof

    The Board of Regents of the University of Texas System · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted

  20. US 9834770

    Single stranded DNA aptamers binding NF-kB/RelA

    The Board of Regents of the University of Texas System · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  21. US 9827327

    Methods and compositions related to adenoassociated virus-phage particles

    The Board of Regents of the University of Texas System · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted

  22. US 9827202

    Hot-melt extrusion of modified release multi-particulates

    The Board of Regents of the University of Texas System · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted

  23. US 9822184

    DCLK1 short form specific binding agents

    The Board of Regents of the University of Texas System · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  24. US 9821006

    Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system

    The Board of Regents of the University of Texas System · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.